APA
GSK icon

American Portfolios Advisors’s GSK GSK Stock Holding History

American Portfolios Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$378K Sell
12,831
-12
-0.1% -$455 0.02% 758
2022
Q2 		$699K Sell
12,843
-695
-5% -$38.4K 0.03% 539
2022
Q1 		$737K Buy
13,538
+2,072
+18% +$113K 0.03% 581
2021
Q4 		$632K Buy
11,466
+2,440
+27% +$127K 0.02% 638
2021
Q3 		$431K Sell
9,026
-45
-0.5% -$2.26K 0.02% 767
2021
Q2 		$452K Sell
9,071
-494
-5% -$23.7K 0.02% 757
2021
Q1 		$427K Sell
9,565
-673
-7% -$30.5K 0.02% 718
2020
Q4 		$471K Sell
10,238
-580
-5% -$26.6K 0.02% 574
2020
Q3 		$509K Sell
10,818
-496
-4% -$24.9K 0.03% 480
2020
Q2 		$577K Buy
11,314
+187
+2% +$9.59K 0.04% 401
2020
Q1 		$527K Buy
11,127
+196
+2% +$10.5K 0.04% 355
2019
Q4 		$642K Buy
10,931
+375
+4% +$20.9K 0.05% 360
2019
Q3 		$563K Buy
10,556
+1,190
+13% +$61.2K 0.05% 363
2019
Q2 		$469K Buy
9,366
+53
+0.6% +$2.66K 0.04% 413
2019
Q1 		$486K Buy
9,313
+1,719
+23% +$85.9K 0.05% 377
2018
Q4 		$363K Sell
7,594
-1,500
-16% -$73.9K 0.04% 361
2018
Q3 		$457K Sell
9,094
-752
-8% -$38.2K 0.05% 342
2018
Q2 		$496K Buy
9,846
+628
+7% +$31.6K 0.07% 283
2018
Q1 		$450K Buy
9,218
+2,304
+33% +$107K 0.07% 284
2017
Q4 		$307K Buy
+6,914
New +$319K 0.05% 364

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

American Portfolios Advisors's GSK Position: Q3 2022 in Review

American Portfolios Advisors reduced its GSK (GSK) stake by 0.09% in Q3 2022, selling an estimated $455 and leaving 12,831 shares worth $378K. The position accounts for 0.02% of the portfolio, ranked #758.

American Portfolios Advisors first reported a position in GSK in Q4 2017 and has held it in 20 quarters since. The position peaked at $737K in Q1 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • American Portfolios Advisors held 12,831 shares of GSK worth $378K as of Q3 2022.
  • American Portfolios Advisors sold 12 GSK shares in Q3 2022, an estimated $455.
  • GSK made up 0.02% of American Portfolios Advisors's portfolio in Q3 2022, its #758 holding.
  • American Portfolios Advisors first reported a position in GSK in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's GSK position peaked at $737K in Q1 2022.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.